The concept of immunophenotypes (i.e., inflamed, excluded, and desert) based on the spatial distribution of CD8+ TILs, which recognized as vital players in modulating tumor progression and influencing responses to immunotherapies, was introduced in 2016 [12]. This evidence concerns the gene CD8A and neoplasm.